Supernus (SUPN) EBITDA (2022 - 2026)
Supernus Pharmaceuticals' EBITDA was $44.81 million in Q3 2026, compared with -$35.43 million a year earlier.
Powered by 
Analysis
Supernus (SUPN) EBITDA (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Supernus Pharmaceuticals' EBITDA was -$1.76 million through Sep 30, 2026; for FY2025, it came in at $29.28 million, down 81.9% from FY2024.
- EBITDA shows a five-year compound annual growth rate of -32.5% (FY2020 to FY2025).
- In earlier years, EBITDA was $162.08 million in FY2024 (+102.3%), $80.12 million in FY2023 (-40.1%), $133.78 million in FY2022 (-1.7%) and $136.13 million in FY2021 (-34.7%).
- The Q3 2026 figure marks the highest quarterly EBITDA since Q3 2024.
- Compared with a year earlier, EBITDA was higher in 1 of the last four quarters, with an average decline of 4.5%.
- The best year-over-year quarter for EBITDA over five years was Q4 2022 (growth of 139.4%); the worst was Q2 2023 (a decline of 90.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Supernus | 3.39 Bn | 2.50 Bn | 305.00 Mn | 181.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 181.00 Mn |
| Jun 30, 2026 | 162.00 Mn |
| Mar 31, 2026 | 139.00 Mn |
| Dec 31, 2025 | 83.00 Mn |
| Sep 30, 2025 | 46.00 Mn |
| Jun 30, 2025 | 74.00 Mn |
| Mar 31, 2025 | 69.00 Mn |
| Dec 31, 2024 | 51.00 Mn |
| Sep 30, 2024 | 39.00 Mn |
| Jun 30, 2024 | -116.00 Mn |
| Mar 31, 2024 | 80.00 Mn |
| Dec 31, 2023 | 62.00 Mn |
| Sep 30, 2023 | -177.00 Mn |
| Jun 30, 2023 | 64.00 Mn |
| Mar 31, 2023 | 61.00 Mn |
| Dec 31, 2022 | -253.00 Mn |
| Sep 30, 2022 | 60.00 Mn |
API Access
Supernus EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();